COVID-19-Related Pulmonary Conditions and Their Treatment
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 5946
Special Issue Editor
Interests: general thoracic surgery; lung cancer; video-assisted thoracoscopic surgery (VATS); nutrition support team (NST); infectious diseases; COVID-19
Special Issue Information
Dear Colleagues,
This Special Issue, “COVID-19-Related Pulmonary Conditions and Their Treatment”, will mainly focus on coronavirus disease 2019 (COVID-19) and pulmonary conditions caused by COVID-19.
COVID-19 is a disease caused by a virus named SARS-CoV-2. Due to its contagiousness, it has quickly spread around the world. Globally, as of 5 January 2023, there have been 657,430,133 confirmed cases of COVID-19, including 6,676,645 deaths, reported to WHO.
Most people with COVID-19 have mild symptoms, but some people become severely ill, some of which are severe pulmonary conditions which necessitate mechanical ventilation.
A deep understanding of COVID-19-related pulmonary conditions can help us to treat patients with pulmonary conditions. We thus consider this subject to be of particular interest; the topic has the potential to expand biomedicine toward new horizons.
We cordially invite authors in the field to submit original research and review articles regarding COVID-19-related pulmonary conditions and their treatment, pertaining to this important and fast-progressing field of biomedicine.
Dr. Teruya Komatsu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- dexamethasone
- ground glass opacity
- pneumonia
- remdesivir SARS-CoV-2
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.